You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 22, 2026
Sale
Calculated transaction value
$418.65K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 21, 2026
Public filing date
Sep 22, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$493.1
Sep 21, 2026
First close after public filing
$489.42
Sep 23, 2026
30-day return after filing
+19.49%
Through Oct 22, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 843 shares @ $496.62
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000146
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$5.82M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 21, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 21, 2026 | $749.32K |
| United Therapeutics Corp UTHR | Sale | Sep 21, 2026 | $1.32M |
| United Therapeutics Corp UTHR | Sale | Sep 21, 2026 | $1.07M |
| United Therapeutics Corp UTHR | Sale | Sep 21, 2026 | $1.13M |
| United Therapeutics Corp UTHR Current | Sale | Sep 21, 2026 | $418.65K |
| United Therapeutics Corp UTHR | Exercise | Sep 21, 2026 | $0 |